![]() |
|
|
Vol. 17, Issue 1, 146-154, January 2006
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||






* Department of Pharmacology, The Skirball Institute, New York University School of Medicine, New York, NY 10016;
Departments of Pediatric Cardiology, The Skirball Institute, New York University School of Medicine, New York, NY 10016; and
Departments of Division of Nephrology, The Skirball Institute, New York University School of Medicine, New York, NY 10016
Submitted August 15, 2005;
Revised September 20, 2005;
Accepted October 14, 2005
Monitoring Editor: Guido Guidotti
KCa3.1 is an intermediate conductance Ca2+-activated K+ channel that is expressed predominantly in hematopoietic cells, smooth muscle cells, and epithelia where it functions to regulate membrane potential, Ca2+ influx, cell volume, and chloride secretion. We recently found that the KCa3.1 channel also specifically requires phosphatidylinositol-3 phosphate [PI(3)P] for channel activity and is inhibited by myotubularin-related protein 6 (MTMR6), a PI(3)P phosphatase. We now show that PI(3)P indirectly activates KCa3.1. Unlike KCa3.1 channels, the related KCa2.1, KCa2.2, or KCa2.3 channels do not require PI(3)P for activity, suggesting that the KCa3.1 channel has evolved a unique means of regulation that is critical for its biological function. By making chimeric channels between KCa3.1 and KCa2.3, we identified a stretch of 14 amino acids in the carboxy-terminal calmodulin binding domain of KCa3.1 that is sufficient to confer regulation of KCa2.3 by PI(3)P. However, mutation of a single potential phosphorylation site in these 14 amino acids did not affect channel activity. These data together suggest that PI(3)P and these 14 amino acids regulate KCa3.1 channel activity by recruiting an as yet to be defined regulatory subunit that is required for Ca2+ gating of KCa3.1.
These authors contributed equally to this work.
Address correspondence to: Edward Skolnik (skolnik{at}saturn.med.nyu.edu).
This article has been cited by other articles:
![]() |
L. Al-Qusairi, N. Weiss, A. Toussaint, C. Berbey, N. Messaddeq, C. Kretz, D. Sanoudou, A. H. Beggs, B. Allard, J.-L. Mandel, et al. T-tubule disorganization and defective excitation-contraction coupling in muscle fibers lacking myotubularin lipid phosphatase PNAS, November 3, 2009; 106(44): 18763 - 18768. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Klein, L. Garneau, N. T. N. Trinh, A. Prive, F. Dionne, E. Goupil, D. Thuringer, L. Parent, E. Brochiero, and R. Sauve Inhibition of the KCa3.1 channels by AMP-activated protein kinase in human airway epithelial cells Am J Physiol Cell Physiol, February 1, 2009; 296(2): C285 - C295. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. L. Robinson, I. R. Niesman, K. K. Beiswenger, and J. E. Dixon Loss of the inactive myotubularin-related phosphatase Mtmr13 leads to a Charcot-Marie-Tooth 4B2-like peripheral neuropathy in mice PNAS, March 25, 2008; 105(12): 4916 - 4921. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Bajwa, A. Alioua, J. W. Lee, D. S. Straus, L. Toro, and C. Lytle Fenofibrate inhibits intestinal Cl secretion by blocking basolateral KCNQ1 K+ channels Am J Physiol Gastrointest Liver Physiol, December 1, 2007; 293(6): G1288 - G1299. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Choudhury, S. Srivastava, Z. Li, K. Ko, M. Albaqumi, K. Narayan, W. A. Coetzee, M. A. Lemmon, and E. Y. Skolnik Specificity of the Myotubularin Family of Phosphatidylinositol-3-phosphatase Is Determined by the PH/GRAM Domain J. Biol. Chem., October 20, 2006; 281(42): 31762 - 31769. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Srivastava, K. Ko, P. Choudhury, Z. Li, A. K. Johnson, V. Nadkarni, D. Unutmaz, W. A. Coetzee, and E. Y. Skolnik Phosphatidylinositol-3 Phosphatase Myotubularin-Related Protein 6 Negatively Regulates CD4 T Cells Mol. Cell. Biol., August 1, 2006; 26(15): 5595 - 5602. [Abstract] [Full Text] [PDF] |
||||